Professor, Dermatology, Yale University School of Medicine
Dermatology
Dr. Michael Girardi, MD
|
|
Give Review
Michael Girardi, MD works in the field of Dermatology. He graduated from Yale University School of Medicine. Yale University School of Medicine is a one of the best medicals schools. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Elected Member" and "Fellow (FAAD)". Dr. Michael Girardi is a published doctor. He has 52 papers published. The most current publication "Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-V chain restriction." Doctor Michael Girardi, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Cutaneous T-Cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-Cell receptor (TCR)-Vβ chain restriction.
- Genomic landscape of cutaneous T Cell lymphoma.
- Langerhans Cells Facilitate UVB-Induced Epidermal Carcinogenesis.
- Hematopoietic stem Cell transplantation for primary cutaneous gammadelta T-Cell lymphoma and refractory subcutaneous panniculitis-like T-Cell lymphoma.
- Mechanisms of Chemical Cooperative Carcinogenesis by Epidermal Langerhans Cells.
- Integrin-driven monocyte to dendritic Cell conversion in modified extracorporeal photochemotherapy.
- IL-9 Regulates Allergen-Specific Th1 Responses in Allergic Contact Dermatitis.
- Induction of monocyte-to-dendritic Cell maturation by extracorporeal photochemotherapy: Initiation via direct platelet signaling.
- Acute toxicity and risk of infection during total Skin electron beam therapy for mycosis fungoides.
- Development of a Plaque Infiltrated With Large CD30+ T Cells Over a Silicone-Containing Device in a Patient With History of Sezary Syndrome.
- Posttraumatic eczema: a manifestation of the Atopic diathesis?
- The pathogenesis of mycosis fungoides.
- Transimmunization for cutaneous T Cell lymphoma: a Phase I study.
- Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal gammadelta T Cells.
- More or less: copy number alterations in mycosis fungoides.
- The contribution of Langerhans Cells to cutaneous malignancy.
- Advances in understanding the immunobiology and immunotherapy of cutaneous T-Cell lymphoma.
- Cutaneous biology of gammadelta T Cells.
- Immunosurveillance and immunoregulation by gammadelta T Cells.
- Selection of the cutaneous intraepithelial gammadelta+ T Cell repertoire by a thymic stromal determinant.
- Nephrogenic systemic fibrosis: a dermatologist's perspective.
- Resident skin-specific gammadelta T Cells provide local, nonredundant regulation of cutaneous inflammation.
- Anti-inflammatory effects in the Skin of thymosin-beta4 splice-variants.
- The distinct contributions of murine T Cell receptor (TCR)gammadelta+ and TCRalphabeta+ T Cells to different stages of chemically induced skin cancer.
- Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations.
- Dialogues in dermatology: Highlights from 2011.
- Gamma delta T Cells provide an early source of interferon gamma in tumor immunity.
- Efficient tumor antigen loading of dendritic antigen presenting Cells by transimmunization.
- Molecular analysis of tumor-promoting CD8+ T Cells in two-stage cutaneous chemical carcinogenesis.
- Langerhans Cells facilitate epithelial DNA damage and squamous Cell carcinoma.
- Rapid generation of maturationally synchronized human dendritic Cells: contribution to the clinical efficacy of extracorporeal photochemotherapy.
- Cutaneous two-stage chemical carcinogenesis.
- Cutaneous perspectives on adaptive immunity.
- Transimmunization, a novel approach for tumor immunotherapy.
- Characterizing the protective component of the alphabeta T Cell response to transplantable squamous Cell carcinoma.
- Selective immmunotherapy through extracorporeal photochemotherapy: yesterday, today, and tomorrow.
- Characterizing tumor-promoting T Cells in chemically induced cutaneous carcinogenesis.
- Environmentally responsive and reversible regulation of epidermal barrier function by gammadelta T Cells.
- Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature.
- Immunosurveillance by gammadelta T Cells: focus on the murine system.
- Clinical and histological findings in nephrogenic systemic fibrosis.
- Primary cutaneous aspergillosis in an immunocompetent patient: successful treatment with oral voriconazole.
- Mycosis fungoides exhibiting features of a dermatofibroma: a case report and review of the literature.
- Cross-comparison of patch test and lymphocyte proliferation responses in patients with a history of acute generalized exanthematous pustulosis.
- Characterization of the DNA Copy-Number Genome in the Blood of Cutaneous T-Cell Lymphoma Patients.
- FDG-PET/CT in the evaluation of cutaneous T-Cell lymphoma.
- FDG-PET/CT for the evaluation of response to therapy of cutaneous T-Cell lymphoma to vorinostat (suberoylanilide hydroxamic acid, SAHA) in a phase II trial.
- Extracorporeal photochemotherapy for generalized deep morphea.
- Pemphigoid vegetans: a case report and review of the literature.
- A transient epidermolysis bullosa simplex-like phenotype associated with bexarotene treatment in a G138E KRT5 heterozygote.
- Familial multiple Basaloid follicular hamartomas: A report of two affected sisters.
Schools
Yale University
Yale New Haven Hospital
Procedures Preformed
- Destruction of Benign Skin Lesion
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Atopic Dermatitis (Eczema)
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
- Fellow (FAAD)
Education
-
Yale-New Haven Hospital -
Yale University School of Medicine
Hospital
-
Yale-New Haven Hospital
Drug Facts
| NPI NUMBER | 1154302842 | |
| NPPES Provider LastName | GIRARDI | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 065103221 | |
| NPPES Provider State | CT | |
| Specialty Description | Dermatology | |
| Total Claim Count | 353.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1154302842 |
| Last Name Of The Provider | GIRARDI |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Nathan H. Brewer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oscar R. Colegio, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David J. Leffell, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Richard L. Edelson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaehyuk Choi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel E. Book, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abigail H. Baird, MD |
|
|
Dr. Neville Kirsch, MD |
|
|
Dr. Teri Greiling, MD |
|
|
Dr. Matthew D. Vesely, MD |
|
|
Dr. Amanda E. Zubek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James Dunlop, MD |
|
|
Dr. David Khalil, MD |